Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study for the Use of Tyrosine Kinase Inhibitors for Treatment of Cognitive Decline Due to Degenerative Dementias

NCT02921477 is registered in ClinicalTrials.gov with Neurological Associates of West Los Angeles as lead sponsor.

NCT NCT02921477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02921477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study for the Use of Tyrosine Kinase Inhibitors for Treatment of Cognitive Decline Due to Degenerative Dementias
Lead sponsor
Neurological Associates of West Los Angeles
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 31, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, mild cognitive impairment